Literature DB >> 12439931

Establishment of a simple assay in vitro for hepatitis C virus NS3 serine protease based on recombinant substrate and single-chain protease.

Gui-Xin Du1, Li-Hua Hou, Rong-Bin Guan, Yi-Gang Tong, Hai-Tao Wang.   

Abstract

AIM: To establish a simple and convenient assay in vitro for the Hepatitis C virus NS3 serine protease based on the recombinant protease and substrate, and to evaluate its feasibility in screening the enzyme inhibitors.
METHODS: Based on the crystallographic structure of hepatitis C virus (HCV) serine protease, a novel single-chain serine protease was designed, in which the central sequence of cofactor NS4A was linked to the N-terminus of NS3 serine protease domain via a flexible linker GSGS. The fusion gene was obtained by two-step PCR that was carried out with three primers and then cloned into the prokaryotic expression vector pQE30, and the recombinant clone was verified by DNA sequencing. The single-chain recombinant protease was expressed when the E.coli was induced with IPTG and the expression conditions were optimized to produce large amount of soluble protease. The recombinant substrate NS5ab that covers the cleavage point NS5A/B was also expressed in E.coli. Both of the protease and substrate were purified by using Ni-NTA agarose metal affinity resin, then they were mixed together in a specific buffer, and the mixture was analyzed by SDS-PAGE. The cleavage system was used to evaluate some compounds for their inhibitory activity on serine protease.
RESULTS: The single-chain recombinant protease was over-expressed as soluble protein when the E.coli was induced at a low dosage of IPTG (0.2 mM) and cultured at a low temperature (15 degrees ). The protease was purified by using Ni-NTA agarose metal affinity resin (the purity is over 95 %). The recombinant substrate NS5ab was expressed in an insoluble form and could refold successfully after purification and dialysis. A simple and convenient assay in vitro was established, in which the purified single-chain serine protease could cleave the recombinant substrate NS5ab into two fragments that were visualized by SDS-PAGE. PMSF had an effect on inhibiting activity of serine protease, while EDTA had not.
CONCLUSION: A simple and convenient assay in vitro for hepatitis C virus NS3 serine protease is based on recombinant substrate NS5ab and single-chain serine protease. This assay can be used in screening of enzyme inhibitors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12439931      PMCID: PMC4656386          DOI: 10.3748/wjg.v8.i6.1088

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  39 in total

Review 1.  Advances in Escherichia coli production of therapeutic proteins.

Authors:  J R Swartz
Journal:  Curr Opin Biotechnol       Date:  2001-04       Impact factor: 9.740

2.  Nucleotide sequence of the genomic RNA of hepatitis C virus isolated from a human carrier: comparison with reported isolates for conserved and divergent regions.

Authors:  H Okamoto; S Okada; Y Sugiyama; K Kurai; H Iizuka; A Machida; Y Miyakawa; M Mayumi
Journal:  J Gen Virol       Date:  1991-11       Impact factor: 3.891

3.  Crystal structure of the hepatitis C virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide.

Authors:  J L Kim; K A Morgenstern; C Lin; T Fox; M D Dwyer; J A Landro; S P Chambers; W Markland; C A Lepre; E T O'Malley; S L Harbeson; C M Rice; M A Murcko; P R Caron; J A Thomson
Journal:  Cell       Date:  1996-10-18       Impact factor: 41.582

4.  Expression of highly active recombinant NS3 protease domain of hepatitis C virus in E. coli.

Authors:  D Vishnuvardhan; N Kakiuchi; P T Urvil; K Shimotohno; P K Kumar; S Nishikawa
Journal:  FEBS Lett       Date:  1997-02-03       Impact factor: 4.124

5.  A novel recombinant single-chain hepatitis C virus NS3-NS4A protein with improved helicase activity.

Authors:  A Y Howe; R Chase; S S Taremi; C Risano; B Beyer; B Malcolm; J Y Lau
Journal:  Protein Sci       Date:  1999-06       Impact factor: 6.725

Review 6.  Hepatitis C virus protease inhibitors: current progress and future challenges.

Authors:  C Steinkühler; U Koch; F Narjes; V G Matassa
Journal:  Curr Med Chem       Date:  2001-07       Impact factor: 4.530

7.  Development of a high throughput scintillation proximity assay for hepatitis C virus NS3 protease that reduces the proportion of competitive inhibitors identified.

Authors:  A Fowler; M Price-Jones; K Hughes; J Anson; R Lingham; M Schulman
Journal:  J Biomol Screen       Date:  2000-06

8.  Structure and organization of the hepatitis C virus genome isolated from human carriers.

Authors:  A Takamizawa; C Mori; I Fuke; S Manabe; S Murakami; J Fujita; E Onishi; T Andoh; I Yoshida; H Okayama
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

9.  The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team.

Authors:  M J Alter; H S Margolis; K Krawczynski; F N Judson; A Mares; W J Alexander; P Y Hu; J K Miller; M A Gerber; R E Sampliner
Journal:  N Engl J Med       Date:  1992-12-31       Impact factor: 91.245

10.  Enzymatic characterization of purified NS3 serine proteinase of hepatitis C virus expressed in Escherichia coli.

Authors:  A Mori; K Yamada; J Kimura; T Koide; S Yuasa; E Yamada; T Miyamura
Journal:  FEBS Lett       Date:  1996-01-02       Impact factor: 4.124

View more
  6 in total

1.  In vitro assay for HCV serine proteinase expressed in insect cells.

Authors:  Li-Hua Hou; Gui-Xin Du; Rong-Bin Guan; Yi-Gang Tong; Hai-Tao Wang
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

2.  Mutations in HCV non-structural genes do not contribute to resistance to nitazoxanide in replicon-containing cells.

Authors:  Changsuek Yon; Prasanth Viswanathan; Jean-François Rossignol; Brent Korba
Journal:  Antiviral Res       Date:  2011-06-14       Impact factor: 5.970

3.  Establishment of a cell-based assay system for hepatitis C virus serine protease and its primary applications.

Authors:  Hong-Xia Mao; Shui-Yun Lan; Yun-Wen Hu; Li Xiang; Zheng-Hong Yuan
Journal:  World J Gastroenterol       Date:  2003-11       Impact factor: 5.742

4.  Comparative molecular dynamics simulation of Hepatitis C Virus NS3/4A protease (Genotypes 1b, 3a and 4b) predicts conformational instability of the catalytic triad in drug resistant strains.

Authors:  Mitchell Kramer; Daniel Halleran; Moazur Rahman; Mazhar Iqbal; Muhammad Ikram Anwar; Muhmad Ikram Anwar; Salwa Sabet; Edward Ackad; Mohammad S Yousef; Mohammad Yousef
Journal:  PLoS One       Date:  2014-08-11       Impact factor: 3.240

5.  A 3D structural model and dynamics of hepatitis C virus NS3/4A protease (genotype 4a, strain ED43) suggest conformational instability of the catalytic triad: implications in catalysis and drug resistivity.

Authors:  Bradley Rimmert; Salwa Sabet; Edward Ackad; Mohammad S Yousef
Journal:  J Biomol Struct Dyn       Date:  2013-06-14

6.  The NS4A Cofactor Dependent Enhancement of HCV NS3 Protease Activity Correlates with a 4D Geometrical Measure of the Catalytic Triad Region.

Authors:  Hamzah A Hamad; Jeremy Thurston; Thomas Teague; Edward Ackad; Mohammad S Yousef
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.